{
  "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0",
  "docSlug": "a6ecebb143ed44be24e72b777fff8cb3",
  "documentTitle": "argenx SE | Results Presentation Deck | 14 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 14,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a circular process flow diagram to illustrate the company's growth strategy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/3",
  "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0",
  "deckJsonHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0.json",
  "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.9,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Four-step circular process showing Reaching More Patients, Geographic Expansion, Pioneer FcRn Class of Medicines, and Broaden Immunology Pipeline.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "506c2ede-ee40-4432-b92c-3e0f51050eb2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.86,
        "x": 0.07,
        "y": 0.82
      },
      "kind": "list",
      "text": "Double-digit growth quarter over quarter; Approval in Canada; Filing of CIDP sBLA by EOY; GO decision in MMN",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8336adf2-99d8-46f5-870a-24e5070483aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.62,
        "x": 0.19,
        "y": 0.19
      },
      "kind": "title",
      "text": "Consistent Execution + Perpetual Innovation",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f647c1fe-e195-48f3-a965-4471d102921b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Driving Sustained Growth Across the Business",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78b3315f-2386-43a9-8667-977c2186be5b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Flywheel",
      "slug": "flywheel",
      "agent": null,
      "layer": "slide",
      "matchId": "23e7f682-659a-48ec-bf74-0c03bee66a36",
      "evidence": "The slide presents a four-step circular process showing Reaching More Patients, Geographic Expansion, Pioneer FcRn Class of Medicines, and Broaden Immunology Pipeline, indicating a flywheel effect.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "flywheel",
      "slug": null,
      "matchId": "908c3800-7a06-406f-b992-9fd097022b5f",
      "evidence": "The circular arrows connecting the four strategic pillars suggest a self-reinforcing growth model.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 4,
      "from": 3,
      "beatId": "03dc2166-e1da-46b9-bed1-765f6d705cf1",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Key Takeaways",
      "beatSlug": null,
      "evidence": "The key takeaways slides provide an overview of the company's current state and goals.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}